Clinical Trials Logo

Respiratory Tract Infections clinical trials

View clinical trials related to Respiratory Tract Infections.

Filter by:

NCT ID: NCT02554383 Completed - Clinical trials for Respiratory Tract Infections

Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?

Start date: February 2016
Phase: Phase 3
Study type: Interventional

The objective of this trial is to determine whether certain subgroups of children with acute sinusitis exist in whom antibiotic therapy can be appropriately withheld.

NCT ID: NCT02539277 Recruiting - Clinical trials for Acute Upper Respiratory Infection

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection

Start date: December 2014
Phase: Phase 4
Study type: Interventional

Study topic:A comparative effectiveness research on Jinyebaidu granule in treating patients with acute upper respiratory infection: A double blind, double dummy, randomized, controlled trial. It is a post-marketing clinical study to evaluate effectiveness, safety and cost-effectiveness on Jinyebaidu granule in treating acute upper respiratory infection. Objectives of Study:This study aims to evaluate effectiveness, safety and cost-effectiveness on Jinyebaidu granule in treating patients with acute upper respiratory infection. Study design:multi-center double-blind, double-dummy, randomized, controlled trial

NCT ID: NCT02512614 Completed - Fever Clinical Trials

Evaluation of Novel Antimicrobial Hand Towels

Start date: March 2012
Phase: Phase 2/Phase 3
Study type: Interventional

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections, self-reported fever, and skin infections in children <2 years old.

NCT ID: NCT02498587 Recruiting - Clinical trials for Severe Acute Respiratory Infection

Short Period Incidence Study of Severe Acute Respiratory Illness

SPRINT-SARI
Start date: January 2016
Phase:
Study type: Observational

This is a multi-centre, prospective, short period incidence observational study of patients in participating hospitals and intensive care units (ICUs) with SARI. The study period will occur, in both Northern and Southern hemispheric winters. The study period will comprise a 5 to 7-day cohort study in which patients meeting a SARI case-definition, who are newly admitted to the hospitals / ICUs at participating sites, will be included in the study. The study will be conducted in 20 to 40-hospital/ ICU-based research networks globally. All clinical information and sample data will only be recorded if taken as part of the routine clinical practice at each site and only fully anonymised and de-identified data will be submitted centrally. The primary aim of this study is to establishing a research response capability for a future epidemic / pandemic through a global SARI observational study. The secondary aim of this study is to investigate the descriptive epidemiology and microbiology profiles of patients with SARI. The tertiary aim of this study is to assess the Ethics, Administrative, Regulatory and Logistic (EARL) barriers to conducting pandemic research on a global level.

NCT ID: NCT02491684 Completed - Asthma Clinical Trials

A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection

INEXAS
Start date: July 21, 2015
Phase: Phase 2
Study type: Interventional

A study to investigate if inhaled Interferon beta-1a is safe and tolerated, and can prevent or reduce the severity of asthma attacks when administered to asthma patients at the onset of symptoms of common cold or influenza

NCT ID: NCT02491164 Completed - Clinical trials for Respiratory Infections

Exploratory Study of Intrapulmonary Microdosing of Gram-negative Optical Imaging Detection Probe

BAC TWO
Start date: April 2016
Phase: Early Phase 1
Study type: Interventional

Critically ill patients are often ventilated in dedicated critical care units to provide respiratory support. Despite best practice patients can often develop a condition called adult respiratory distress syndrome (ARDS), which is characterised by deterioration in their respiratory function, and changes on chest x-ray. The correct management for ARDS is identifying the underlying condition causing the deterioration and identifying appropriate targeted therapy. One such cause is pneumonia, caused by a bacterial infection in the lungs of a ventilated patient. The patients may have been ventilated due to pneumonia but they may also develop pneumonia whilst ventilated. Ventilator associated pneumonia (VAP) has significant mortality. Despite all the clinical and laboratory data at the investigators' disposal there remains great difficulty in the accurate diagnosis of pneumonia and therefore treatment is often given empirically. Therefore, there is an urgent clinical need for accurate methods to diagnose the presence of bacteria deep in the lung in ventilated critically ill patients. As such, the investigating team have developed and synthesised an imaging agent called BAC TWO. BAC TWO will be instilled directly into the lungs of 12 patients to assess whether it can label gram-negative bacteria in the human lung.

NCT ID: NCT02484417 Completed - Clinical trials for Upper Respiratory Tract Infection

Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers

Start date: July 21, 2015
Phase: Phase 1
Study type: Interventional

Background: - Respiratory syncytial virus (RSV) can cause respiratory infections. Some of these can be life-threatening, especially in young children, the elderly, and people with weak immune systems. Researchers want to study RSV infection in a hospital setting in healthy adults. They want to use what they learn to test new treatments or vaccines in the future. Objectives: - To study how the body responds to RSV. Eligibility: - Healthy volunteers ages 18-50 Design: - Participants will be screened under another protocol. - Participants will have: - Medical history - Physical exams - EKG. Heart rhythm is measured with small sticky patches on the chest, arms, and legs. - Chest x-ray - Pulmonary function tests. This measures how much air a person can move into and out of the lungs. - Blood and urine tests - Nasal washes and/or nasal swabs. For the wash, the nose will be rinsed with a sterile liquid. For the swab, the inside of the nostril will be rubbed with a cotton swab. - Participants will have two, possibly three, follow-up outpatient visits, approximately 1, 2 and 6 months after receiving the dose of RSV. - Participants will stay in the hospital under isolation for 7 or more days after getting the virus. - The average stay is 10 days. Participants cannot leave the isolation unit. They cannot have visitors. - The virus should cause a mild to medium cold. - Participants will fill out a symptom card every day in the hospital and for 1 month after. - Participants will have 2 follow-up visits, 28 and 56 days after leaving the hospital. - Female participants who are sexually active must remain abstinent or use an effective form of birth control for 1 month before and after getting the virus.

NCT ID: NCT02473796 Completed - Malaria Clinical Trials

Home Based Child Care to Reduce Mortality and Malnutrition in Tribal Children of Melghat, India: CRCT

HBCC
Start date: January 2004
Phase: N/A
Study type: Interventional

Melghat is poorly developed tribal area in India with very high child mortality & malnutrition prevalence (grossly inadequate medical facilities). Important health problems. Malnutrition , Pneumonia, Tuberculosis, Anaemia, Malaria, Diarrhoea, Premature and L. B. W. babies, Neonatal sepsis, Feeding problem, Birth asphyxia. The investigators developed a Home Based Child Care (HBCC) model to reduce neonatal mortality rate (NMR), infant mortality rate (IMR), under 5 mortality rate (U5MR) and severe malnutrition(SM) in this region. Melghat. Need of project : Melghat is known for highest U5MR in Maharashtra. Overall aims and importance of the research:. The results obtained in this area will be applicable for reducing children mortality and malnutrition in other parts of Melghat and all other tribal areas of India. Methodology: RCT-Home based child care (HBCC) by trained village health workers .(ARI, Diarrhoea, Malaria clinically & Neonatal care) in 19 villages. Strengthening of existing government ICDS and health system. Melghat. Need of project : Melghat is known for highest U5MR in Maharashtra. Overall aims and importance of the research:. The results obtained in this area will be applicable for reducing children mortality and malnutrition in other parts of Melghat and all other tribal areas of India. Methodology: RCT- (HBCC) by trained village health workers .(ARI, Diarrhoea, Malaria clinically & Neonatal care) in 19 villages.

NCT ID: NCT02454114 Completed - Clinical trials for Community Acquired Pneumonia

HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections

HOMEFIRST
Start date: October 2013
Phase: N/A
Study type: Interventional

HOME FIRST (Home Followed - up with Infection Respiratory Support Team) is an early supported discharge scheme. It will enable patients with lower respiratory tract infection (LRTI) to be provided with high quality safe, effective, efficient patient centred care, tailored to their needs in their own home; aiming to improve the overall experience of the service user, improve patient outcomes and reduce hospital length of stay whilst simultaneously reducing admission rates, an area of major strategic importance to the NHS.

NCT ID: NCT02451163 Completed - Common Cold Clinical Trials

DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly

Fib-CC-2014
Start date: September 2014
Phase: Phase 2
Study type: Interventional

The aim of the study is to measure the effect of wheat polysaccharides on the occurence of common cold (CC) in elderly during a 12-week consumption period.